SG11201700536XA - Formulation comprising glycopyrrolate, method and apparatus - Google Patents
Formulation comprising glycopyrrolate, method and apparatusInfo
- Publication number
- SG11201700536XA SG11201700536XA SG11201700536XA SG11201700536XA SG11201700536XA SG 11201700536X A SG11201700536X A SG 11201700536XA SG 11201700536X A SG11201700536X A SG 11201700536XA SG 11201700536X A SG11201700536X A SG 11201700536XA SG 11201700536X A SG11201700536X A SG 11201700536XA
- Authority
- SG
- Singapore
- Prior art keywords
- glycopyrrolate
- formulation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4704—2-Quinolinones, e.g. carbostyril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5015—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5192—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Nanotechnology (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14184164 | 2014-09-09 | ||
| PCT/EP2015/070660 WO2016038116A1 (en) | 2014-09-09 | 2015-09-09 | Formulation comprising glycopyrrolate, method and apparatus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201700536XA true SG11201700536XA (en) | 2017-02-27 |
Family
ID=51542160
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201700536XA SG11201700536XA (en) | 2014-09-09 | 2015-09-09 | Formulation comprising glycopyrrolate, method and apparatus |
Country Status (38)
| Country | Link |
|---|---|
| US (2) | US10532041B2 (pl) |
| EP (2) | EP3191081B1 (pl) |
| JP (1) | JP6502501B2 (pl) |
| KR (1) | KR101927960B1 (pl) |
| CN (1) | CN106604720B (pl) |
| AP (1) | AP2017009777A0 (pl) |
| AR (1) | AR101793A1 (pl) |
| AU (1) | AU2015314272B2 (pl) |
| BR (1) | BR112017003888B1 (pl) |
| CA (1) | CA2960694C (pl) |
| CL (1) | CL2017000560A1 (pl) |
| CO (1) | CO2017003056A2 (pl) |
| CY (1) | CY1124569T1 (pl) |
| DK (1) | DK3191081T3 (pl) |
| DO (1) | DOP2017000065A (pl) |
| EA (1) | EA037332B1 (pl) |
| EC (1) | ECSP17021465A (pl) |
| ES (1) | ES2793905T3 (pl) |
| HR (1) | HRP20201005T1 (pl) |
| HU (1) | HUE049339T2 (pl) |
| IL (1) | IL250427A0 (pl) |
| LT (1) | LT3191081T (pl) |
| MA (2) | MA40617B1 (pl) |
| MX (1) | MX2017003080A (pl) |
| MY (1) | MY181647A (pl) |
| NZ (1) | NZ728435A (pl) |
| PH (1) | PH12017500303A1 (pl) |
| PL (1) | PL3191081T3 (pl) |
| PT (1) | PT3191081T (pl) |
| RS (1) | RS60299B1 (pl) |
| SG (1) | SG11201700536XA (pl) |
| SI (1) | SI3191081T1 (pl) |
| SV (1) | SV2017005403A (pl) |
| TN (1) | TN2017000077A1 (pl) |
| TW (1) | TWI602566B (pl) |
| UA (1) | UA115958C2 (pl) |
| WO (1) | WO2016038116A1 (pl) |
| ZA (1) | ZA201700658B (pl) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3595631A1 (en) * | 2017-03-15 | 2020-01-22 | Vectura Limited | Method and formulation |
| CN112137957B (zh) * | 2019-06-26 | 2022-07-29 | 长风药业股份有限公司 | 一种药用吸入气雾剂及其制备方法 |
| WO2021143785A1 (zh) * | 2020-01-15 | 2021-07-22 | 四川海思科制药有限公司 | 一种含茚达特罗的吸入气雾剂药物组合物及其制备方法 |
Family Cites Families (55)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2956062A (en) | 1959-02-26 | 1960-10-11 | Robins Co Inc A H | Esters of amino alcohols |
| SE9302777D0 (sv) | 1993-08-27 | 1993-08-27 | Astra Ab | Process for conditioning substances |
| GB9501841D0 (en) | 1995-01-31 | 1995-03-22 | Co Ordinated Drug Dev | Improvements in and relating to carrier particles for use in dry powder inhalers |
| GB9808470D0 (en) | 1998-04-22 | 1998-06-17 | Smithkline Beecham Plc | Novel process and apparatus |
| GB9826284D0 (en) | 1998-12-01 | 1999-01-20 | Rhone Poulence Rorer Limited | Process |
| GB9826286D0 (en) | 1998-12-01 | 1999-01-20 | Rhone Poulence Rorer Limited | Process |
| GB0008660D0 (en) | 2000-04-07 | 2000-05-31 | Arakis Ltd | The treatment of respiratory diseases |
| JP2004515260A (ja) | 2000-04-11 | 2004-05-27 | デュラ・ファーマシューティカルズ・インコーポレイテッド | 物理的に安定化された乾燥粉末製剤 |
| WO2002008470A1 (en) | 2000-07-20 | 2002-01-31 | Campina B.V. | Method for producing a crystalline tableting additive, additive thus obtained and use thereof |
| CA2429665C (en) | 2000-11-30 | 2013-10-22 | Vectura Limited | Method of making particles for use in a pharmaceutical composition |
| GB0030074D0 (en) | 2000-12-08 | 2001-01-24 | Univ London Pharmacy | Particulate inhalation carrier |
| US7309707B2 (en) | 2002-03-20 | 2007-12-18 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament |
| DE10212264A1 (de) | 2002-03-20 | 2003-10-02 | Boehringer Ingelheim Pharma | Kristallines Mikronisat, Verfahren zu dessen Herstellung und dessen Verwendung zur Herstellung eines Arzneimittels |
| ITMI20022674A1 (it) | 2002-12-18 | 2004-06-19 | Chiesi Farma Spa | Procedimento per la preparazione di formulazioni sterili a base di principi attivi farmaceutici cristallini micronizzati da somministrare come sospensioni acquose per inalazione. |
| US20040121003A1 (en) | 2002-12-19 | 2004-06-24 | Acusphere, Inc. | Methods for making pharmaceutical formulations comprising deagglomerated microparticles |
| US7188993B1 (en) * | 2003-01-27 | 2007-03-13 | Harold W Howe | Apparatus and method for resonant-vibratory mixing |
| GB0327723D0 (en) | 2003-09-15 | 2003-12-31 | Vectura Ltd | Pharmaceutical compositions |
| GB0321607D0 (en) | 2003-09-15 | 2003-10-15 | Vectura Ltd | Manufacture of pharmaceutical compositions |
| JO3102B1 (ar) | 2004-03-17 | 2017-09-20 | Chiesi Framaceutici S P A | صيغ صيدلانية لوسائل استنشاق بها مسحوق جاف تشتمل على مكون فعال بقوة منخفضة الجرعة |
| GB0409703D0 (en) | 2004-04-30 | 2004-06-02 | Vectura Ltd | Pharmaceutical compositions |
| GB0410398D0 (en) | 2004-05-10 | 2004-06-16 | Arakis Ltd | The treatment of respiratory disease |
| GB0410399D0 (en) * | 2004-05-10 | 2004-06-16 | Arakis Ltd | The treatment of respiratory disease |
| GB0411056D0 (en) | 2004-05-18 | 2004-06-23 | Novartis Ag | Organic compounds |
| GB0425758D0 (en) | 2004-11-23 | 2004-12-22 | Vectura Ltd | Preparation of pharmaceutical compositions |
| US20060292077A1 (en) | 2005-03-18 | 2006-12-28 | Zhao Jonathon Z | Dendritic and star-shaped contrast agents for medical devices and bioabsorbable radiopaque bulk material and method for producing same |
| GB0523653D0 (en) | 2005-11-21 | 2005-12-28 | Novartis Ag | Organic compounds |
| US8074906B2 (en) | 2005-07-07 | 2011-12-13 | Nanotherapeutics, Inc. | Process for milling and preparing powders and compositions produced thereby |
| GB0523654D0 (en) | 2005-11-21 | 2005-12-28 | Novartis Ag | Organic compounds |
| GB0523656D0 (en) | 2005-11-21 | 2005-12-28 | Novartis Ag | Organic compounds |
| GB0523655D0 (en) | 2005-11-21 | 2005-12-28 | Novartis Ag | Organic compounds |
| GB0525254D0 (en) | 2005-12-12 | 2006-01-18 | Jagotec Ag | Powder compositions for inhalation |
| GB0613161D0 (en) * | 2006-06-30 | 2006-08-09 | Novartis Ag | Organic Compounds |
| JP5283835B2 (ja) * | 2006-07-06 | 2013-09-04 | 東京エレクトロン株式会社 | マイクロ波プラズマ処理装置及びマイクロ波プラズマ処理装置用ゲートバルブ |
| EP1894568A1 (en) | 2006-08-31 | 2008-03-05 | Novartis AG | Pharmaceutical compositions for the treatment of inflammatory or obstructive airway diseases |
| EP1944018A1 (en) | 2007-01-10 | 2008-07-16 | CHIESI FARMACEUTICI S.p.A. | Micronised particles of low-dosage strength active agents for powder formulations for inhalation |
| GB0702456D0 (en) | 2007-02-08 | 2007-03-21 | Astrazeneca Ab | New combination |
| KR20100095437A (ko) | 2007-11-07 | 2010-08-30 | 아스트라제네카 아베 | 아스코르브산 유도체를 포함하는 건조 분말 제제 |
| JP2011506400A (ja) | 2007-12-13 | 2011-03-03 | ノバルティス アーゲー | 有機化合物 |
| EP2234595B1 (en) | 2007-12-13 | 2012-11-28 | Novartis AG | Process for reducing the tendency of a glycopyyronium salt to aggegate during storage. |
| US8235314B2 (en) | 2009-02-12 | 2012-08-07 | Linde Aktiengesellschaft | Nonequilibrium humidity control for jet milling |
| EP2417106B1 (en) | 2009-04-09 | 2016-11-30 | Novartis AG | Process for preparing pyrrolidinium salts |
| CN102740836A (zh) | 2009-04-24 | 2012-10-17 | 伊休蒂卡有限公司 | 用于制备商品化纳米颗粒和微粒粉末的方法 |
| CN102858326A (zh) * | 2010-04-01 | 2013-01-02 | 奇斯药制品公司 | 用于制备可吸入干粉所用的载体颗粒的方法 |
| SI2560611T1 (en) | 2010-04-21 | 2018-03-30 | Chiesi Farmaceutici S.P.A. | A process for preparing particles with reduced electrostatic charges |
| US20130157991A1 (en) | 2010-08-31 | 2013-06-20 | Osama Ahmed Aswania | Dry Powder Inhalation Drug Products Exhibiting Moisture Control Properties and Methods of Administering the Same |
| RU2018115685A (ru) | 2011-02-17 | 2019-03-05 | Сипла Лимитед | Фармацевтическая композиция |
| JO3510B1 (ar) * | 2011-03-04 | 2020-07-05 | Heptares Therapeutics Ltd | استخدام جلايكوبيرولات لعلاج عدم انتظام دقات القلب |
| RU2013155903A (ru) | 2011-05-17 | 2015-06-27 | Перл Терапьютикс, Инк. | Композиции, способы и устройства для респираторной доставки двух или более активных средств |
| GB201205632D0 (en) | 2012-03-30 | 2012-05-16 | Vectura Ltd | Method and apparatus |
| WO2014007766A1 (en) | 2012-07-05 | 2014-01-09 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Dry powder inhalers comprising a carrier other than lactose |
| US20150202297A1 (en) | 2012-07-05 | 2015-07-23 | Arven Ilac Sanayi Ve Ticaret Anonim Sirketi | Dry powder inhalers comprising a carrier other than lactose and a ternary component |
| DE102012211907A1 (de) * | 2012-07-09 | 2014-01-09 | Robert Bosch Gmbh | Drehschlagschrauber mit einem Schlagwerk |
| GB201305825D0 (en) | 2013-03-28 | 2013-05-15 | Vectura Ltd | New use |
| WO2014190204A1 (en) | 2013-05-22 | 2014-11-27 | Pearl Therapeutics, Inc. | Compositions, methods & systems for respiratory delivery of three or more active agents |
| WO2015094927A1 (en) | 2013-12-17 | 2015-06-25 | Merck Sharp & Dohme Corp. | Media milling process for the manufacture of active pharmaceutical ingredients in propellants |
-
2015
- 2015-09-09 TW TW104129823A patent/TWI602566B/zh active
- 2015-09-09 CA CA2960694A patent/CA2960694C/en active Active
- 2015-09-09 UA UAA201703025A patent/UA115958C2/uk unknown
- 2015-09-09 PL PL15762595T patent/PL3191081T3/pl unknown
- 2015-09-09 DK DK15762595.5T patent/DK3191081T3/da active
- 2015-09-09 CN CN201580048064.1A patent/CN106604720B/zh active Active
- 2015-09-09 MA MA40617A patent/MA40617B1/fr unknown
- 2015-09-09 ES ES15762595T patent/ES2793905T3/es active Active
- 2015-09-09 KR KR1020177009495A patent/KR101927960B1/ko active IP Right Grant
- 2015-09-09 EP EP15762595.5A patent/EP3191081B1/en active Active
- 2015-09-09 EA EA201790544A patent/EA037332B1/ru unknown
- 2015-09-09 LT LTEP15762595.5T patent/LT3191081T/lt unknown
- 2015-09-09 WO PCT/EP2015/070660 patent/WO2016038116A1/en active Application Filing
- 2015-09-09 SG SG11201700536XA patent/SG11201700536XA/en unknown
- 2015-09-09 MX MX2017003080A patent/MX2017003080A/es active IP Right Grant
- 2015-09-09 PT PT157625955T patent/PT3191081T/pt unknown
- 2015-09-09 MA MA050680A patent/MA50680A/fr unknown
- 2015-09-09 AP AP2017009777A patent/AP2017009777A0/en unknown
- 2015-09-09 NZ NZ728435A patent/NZ728435A/en unknown
- 2015-09-09 HU HUE15762595A patent/HUE049339T2/hu unknown
- 2015-09-09 MY MYPI2017700336A patent/MY181647A/en unknown
- 2015-09-09 EP EP20165232.8A patent/EP3689332A1/en active Pending
- 2015-09-09 US US15/509,769 patent/US10532041B2/en active Active
- 2015-09-09 RS RS20200579A patent/RS60299B1/sr unknown
- 2015-09-09 TN TN2017000077A patent/TN2017000077A1/en unknown
- 2015-09-09 AU AU2015314272A patent/AU2015314272B2/en active Active
- 2015-09-09 AR ARP150102874A patent/AR101793A1/es not_active Application Discontinuation
- 2015-09-09 BR BR112017003888-9A patent/BR112017003888B1/pt active IP Right Grant
- 2015-09-09 SI SI201531220T patent/SI3191081T1/sl unknown
- 2015-09-09 JP JP2017532216A patent/JP6502501B2/ja active Active
-
2017
- 2017-01-26 ZA ZA2017/00658A patent/ZA201700658B/en unknown
- 2017-02-02 IL IL250427A patent/IL250427A0/en active IP Right Grant
- 2017-02-17 PH PH12017500303A patent/PH12017500303A1/en unknown
- 2017-03-07 SV SV2017005403A patent/SV2017005403A/es unknown
- 2017-03-08 CL CL2017000560A patent/CL2017000560A1/es unknown
- 2017-03-08 DO DO2017000065A patent/DOP2017000065A/es unknown
- 2017-03-29 CO CONC2017/0003056A patent/CO2017003056A2/es unknown
- 2017-04-06 EC ECIEPI201721465A patent/ECSP17021465A/es unknown
-
2019
- 2019-12-03 US US16/701,616 patent/US20200155506A1/en not_active Abandoned
-
2020
- 2020-06-17 CY CY20201100560T patent/CY1124569T1/el unknown
- 2020-06-25 HR HRP20201005TT patent/HRP20201005T1/hr unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201606392B (en) | Mobile sterilization apparatus and method for using the same | |
| SG10201406577PA (en) | Method, apparatus, and program | |
| HK1244388A1 (zh) | 方法、裝置和系統 | |
| GB201409086D0 (en) | Apparatus and method | |
| GB201409077D0 (en) | Apparatus and method | |
| GB201409064D0 (en) | Method and apparatus | |
| SG10201408403VA (en) | Evaluation method, and evaluation apparatus | |
| GB201405662D0 (en) | Apparatus and method | |
| PT3210417T (pt) | Método e aparelho para adquirir informações de sistema | |
| SG11201703087WA (en) | Communication apparatus and communication method | |
| GB201417624D0 (en) | Apparatus, system and method | |
| ZA201603217B (en) | Apparatus, program, and method | |
| GB201415599D0 (en) | Method and apparatus | |
| GB201406332D0 (en) | Apparatus and method | |
| IL250427A0 (en) | Formulations containing glycopyrrolate, method and standard | |
| EP3104659A4 (en) | Apparatus and method | |
| EP3119120A4 (en) | Apparatus and method | |
| GB201407801D0 (en) | Apparatus and method | |
| EP3188526A4 (en) | Apparatus and method | |
| EP3151527A4 (en) | Apparatus and method | |
| GB201414572D0 (en) | Apparatus, System and Method | |
| GB201411726D0 (en) | Apparatus and method | |
| GB201411631D0 (en) | Apparatus and method | |
| GB201405663D0 (en) | Apparatus and method | |
| GB201413236D0 (en) | Method and apparatus |